spacer
home > pmps > summer 2009 > securing anti-counterfeiting technologies
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Securing Anti-Counterfeiting Technologies

Using automatic identification methods, such as barcodes or radio frequency identification (RFID), as part of item-level packaging, is seen as a way of protecting pharmaceutical products from counterfeiting and other threats. These technologies can also be used to automate electronic pedigrees, supply chain management, reverse logistics and inventory control. Pharmaceuticals must be protected from counterfeiting and theft because these affect public safety and drive up consumer drug prices. But barcodes and RFID tags used on pharmaceutical packaging must be secured if they are to provide any real protection.

Threats to the pharmaceutical supply chain include stolen products, unapproved generics, re-introduction of expired products, counterfeits, up-labelled products, diverted products, and parallel imports. The World Health Organization estimates that the percentage of drugs which are counterfeit range from around one per cent of sales in developed countries to over 10 per cent in developing countries, depending on the geographical area (1). The US-based Centre for Medicines in the Public Interest estimates that, globally, counterfeit pharmaceutical commerce will grow to become 16 per cent of the aggregate size of the legitimate industry, a six percentage-point increase from 2004. This illegal business will generate $75 billion in revenues for its participants in 2010, a 92 per cent increase from 2005 (2).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Louis Parks is a co-founder of SecureRF. As CEO of the company, Louis has helped to guide the development of new cryptographic solutions and security tools for low-resource and embedded devices like radio frequency identification (RFID) and microcontrollers (MCU). With over 21 years of senior management experience, Louisí primary roles have been in sales and marketing of technology and enterprise software solutions. Prior to co-founding SecureRF, he held operational roles assisting early and mid-stage technology companies with funding, staffing, operations and strategy. His previous positions have included Senior Vice President of Marketing for G-Log, an innovative internet logistics company and 10 years as CEO/President of Client Technologies, Inc, a provider of customer relationship management (CRM) applications specifically designed to serve the financial community.
spacer
Louis Parks
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the £11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners ó Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI ó will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>

White Papers

Tabletability, Compactability, and Compressibilty: Whatís the Difference?

Natoli Engineering Company, Inc.

To patients and consumers, tablets are a simple and convenient dosage form. But the science behind compressing a block of particles or granules into a single tablet can be complicated. Thatís where common compression studies can help. This article explains how to develop tabletability, compactibility, and compressibility profiles.
More info >>

 
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement